Close Menu
March 03, 2020
Sponsored by
Beckman Coulter

Early Sepsis Identification: Clinical and Laboratory Medicine Collaboration Can Improve Patient Outcomes

GenomeWebinar

Professor of Surgery and Emergency Medicine
Washington University School of Medicine

Instructor in the Department of Pathology & Immunology
Washington University, St. Louis

Sepsis is a growing healthcare crisis, causing over 11 million deaths worldwide. Early recognition and timely, comprehensive therapeutic interventions improve patient outcomes and have been codified in current clinical guidelines and government reporting requirements. However, non-specific presenting symptoms that mimic other diagnoses combined with multiple clinical definitions lead to diagnostic uncertainty. Identifying the undiagnosed septic patient within the sea of undifferentiated patients simultaneously presenting to the Emergency Department is challenging and can lead to potential treatment delays with associated increases in morbidity and mortality.

This webinar is presented by Dr. Tiffany Osborn, Professor of Surgery and Emergency Medicine for the Surgical/Trauma Intensive Care Unit and Emergency Department at Washington University School of Medicine and Dr. Christopher Farnsworth, instructor in the Department of Pathology & Immunology at Washington University and medical director of Clinical Chemistry, Point of Care testing, and the Special Pathogens Laboratory at Barnes Jewish Hospital.

During the session, Dr. Osborn and Dr. Farnsworth will discuss how teamwork between the laboratory and clinical medicine can improve patient care through earlier identification and treatment of septic patients. They will discuss the challenges associated with current screening biomarkers, as well as the opportunities presented by a novel sepsis biomarker, monocyte distribution width.

After this webinar, you will be able to:

  • Explain the relationship between early sepsis treatment and improved patient mortality
  • Differentiate among Sepsis-2 and Sepsis-3 definitions and common sepsis screening criteria such as qSOFA and SIRS
  • Review published evidence supporting the effectiveness of monocyte distribution width in early sepsis detection
Sponsored by

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.

CNN reports that two new studies suggest the B.1.1.7 SARS-CoV-2 variant may be more transmissible, but may not lead to more severe disease.

According to the Associated Press, a Swiss program aims to shepherd long-term science projects and diplomacy.

In PNAS this week: analysis of pathway affecting acute kidney injury, parental-specific allelic expression in horse placenta, and more.